Integra Lifesciences Prices $450M Senior Secured Notes

By Bobby Samwell • Saturday, October 10 10:53 • Permanent Link

Integra Lifesciences Holdings priced $450 million of 9.500% senior secured notes due 2033, adding a new layer to a refinancing package that will replace its existing credit facilities.

The company said the notes are expected to close on or about Oct. 19, 2026. Proceeds from the bond sale, together with borrowings under a new credit facility, will be used to refinance current debt and cover related fees and expenses.

The new notes carry a 9.500% coupon and are being issued as senior secured obligations of the company. They will be guaranteed by Integra’s wholly owned domestic subsidiaries that already guarantee its senior secured credit facilities.

Integra said the offering is part of a broader refinancing transaction. The market has reacted to these announcements by moving the company's shares 3.15% to a price of $13.41. If you want to know more, read the company's complete 8-K report here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.